We examined whether upregulation of SPAK–NKCC1 signaling pathway in the CPECs is associated with changes in the TJ integrity and whether pharmacological inhibition of SPAK–NKCC1 complex attenuates stroke-induced ChP blood–CSF barrier dysfunction in ischemic brains. This evidence concerns the gene SLC12A2 and stroke disorder.